News
Erdem Hospital in Istanbul has announced the launch of a new pre-operative education program tailored specifically for ...
The agreement, signed during CPHI China 2025, represents a high-level partnership between two influential players in their ...
Award is one of Houston’s most inspiring celebrations of leadership, where CEOs and visionaries are at the helm of the city’s most successful and impactful organizations ...
AdipoPharma restores the normal function of the adipocyte for the treatment of insulin resistance, type 2 diabetes, and related metabolic disorders. AdipoPharma SAS is headquartered in Strasbourg, ...
NANTES, France, June 30, 2025, 6:00 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces the publication of its inaugural Letter to Shareholders.
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development and diagnostics LONDON, June 30, 2025 (GLOBE NEWSWIRE) -- Portal ...
The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily ...
EUROAPI today announced the signing of a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, the subsidiary operating its Haverhill manufacturing site, with a simultaneous closing ...
ALLENTOWN, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine is redefining convenience in healthcare with the expansion of its HNL Lab Tests Direct menu, adding dozens of new self-pay tests that ...
Total enrollment dipped slightly in 2023 to 87% of the population compared to 88% of the population in 2022 due to Medicaid “unwinding”; however, the mix of benefits enrolled remained very stable in ...
Under their new agreement, the effective royalty rate paid by Biofrontera Inc. will be reduced to 12% (and 15% above revenue of $65 million) of net sales from 25% - 35% of net sales.
This latest token acquisition reflects our deepening commitment to the Hyperliquid network and our long-term conviction in its potential to redefine onchain finance.” The additional holdings are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results